Scroll

Clinical Quality Measures Report - Heart Failure (HF): Angiotensin-Converting Enzyme (ACE) Inhibitor or Angiotensin Receptor Blocker (ARB) or Angiotensin Receptor-Neprilysin Inhibitor (ARNI) Therapy for Left Ventricular Systolic Dysfunction (LVSD)

Overview
This report tracks the percentage of patients aged 18 years and older with a diagnosis of heart failure (HF) with a current or prior left ventricular ejection fraction (LVEF) < 40% who were prescribed ACE inhibitor or ARB or ANRI therapy either within a 12 month period when seen in the outpatient setting OR at each hospital discharge.

A patient will be in the denominator when they have all of the following:

  • An age 18 years or older
  • At least two visits within your reporting period
  • A Heart Failure diagnosis with an Onset Date matching the visit's Procedure Date
  • An Ejection Fraction LNC code entered or imported as a Laboratory Order with a Value <40% and an Ordered Date and a Received Date matching or prior to the first visit's Procedure Date
  • A Moderate or Severe LVSD snomed code added to their EMR or EHR from with a Start Date and End Date matching the Procedure Date of their visit

A patient will be in the numerator when they have all of the following:

  • The patient needs an ACE inhibitor or ARB/ANRI medication with an Ordered Date matching the visit's Procedure Date

A patient will be excluded from the denominator when they have:

  • A Pregnancy, Renal Failure Due to ACE Inhibitor, Intolerance to ACE Inhibitor diagnosis with an Onset Date matching the visit's Procedure Date
  • An Allergy to ACE inhibitor or ERB Allergen snomed code added to their EMR or EHR from with a Start Date and End Date matching the Procedure Date of their visit
Was this article helpful?
0 out of 0 found this helpful
Have more questions? Submit a request

Comments